Neonatal TPN Starter Bags Recalled Due to Sterility Assurance Failure
Central Admixture Pharmacy Services recalls 128 neonatal TPN starter bags distributed nationwide due to lacking validation of decontamination procedures, creating inability to assure product sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves lack of sterility assurance in a neonatal intravenous admixture product, which represents a risk-of-harm scenario for a vulnerable patient population. No illnesses, injuries, or confirmed contamination have been reported; the hazard is theoretical based on the manufacturer's inability to validate adequate decontamination procedures.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 128 neonatal TPN (Total Parenteral Nutrition) starter bags distributed nationwide. The recalled product is a 250mL IV bag containing Amino Acids (trophamine) 2% and Dextrose 10%.
The recall is due to a lack of assurance of sterility. Validation data for the decontamination cycles is lacking, which means the manufacturer cannot confirm that its sterilization process is adequate to ensure product sterility.
This product is used for intravenous administration to neonatal (newborn) patients. The affected lot numbers are 36-251458 (Exp. 7/14/2023), 36-251695 (Exp. 7/15/2023), and 36-256027 (Exp. 7/28/2023), with NDC 72196-0400-1.
Healthcare facilities and pharmacies that received these bags should discontinue use and quarantine any remaining product. Contact Central Admixture Pharmacy Services, Inc. at 2200 South 43rd Avenue, Phoenix, AZ 85043 for recall and return procedures.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (trophamine) 2%/Dextrose 10%, Total Volume = 250mL, IV Bag, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0400-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Neonatal IV Admixture
- Affected units
- 128
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot: 36-251458
- Exp. 7/14/2023
- 36-251695
- Exp. 7/15/2023
- 36-256027
- Exp. 7/28/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 95 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 95 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15